TrialDiabetes, obesity & metabolism2020

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials.

Subodh Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.